Valuation: Enimmune corporation

Market Cap 1.15B 36.07M 31.59M 29.16M 27.23M 51.26M 3.41B 52.42M 351M 135M 1.68B 135M 132M 5.84B P/E 2024
-11.3x
P/E 2025 -9.04x
Enterprise Value 1.1B 34.36M 30.09M 27.78M 25.94M 48.82M 3.25B 49.94M 334M 129M 1.6B 129M 126M 5.56B EV / Sales 2024
35.4x
EV / Sales 2025 29.7x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day+3.24%
1 week-3.04%
Current month-8.33%
1 month-8.33%
3 months-11.39%
6 months-23.32%
Current year-22.57%
1 week 15.4
Extreme 15.4
16.4
1 month 15.4
Extreme 15.4
17.5
Current year 15.4
Extreme 15.4
22.15
1 year 14.65
Extreme 14.65
23.9
3 years 14.65
Extreme 14.65
50.7
5 years 14.65
Extreme 14.65
75.3
10 years 14.49
Extreme 14.49
125
Manager TitleAgeSince
Chief Executive Officer - 06/01/2019
Chief Tech/Sci/R&D Officer - 20/07/2014
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Chairman - 06/01/2019
Director/Board Member - 01/01/2014
Director/Board Member - 18/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
+3.24%-3.04%+4.59%-68.48% 36.07M
+3.28%-0.22%+72.67%+128.25% 55.78B
+6.76%+18.10%+91.66%+104.09% 55.66B
+3.33%+4.51%-11.68%-11.91% 23.84B
+1.32%+6.22%+5.28%+415.45% 22.7B
+7.13%+8.19%+40.57%-28.35% 16.12B
-0.89%+5.71%+24.30%+186.29% 13.64B
+9.96%+15.98%+157.65%+310.89% 14.8B
+2.85%+2.81%+75.32%+139.44% 12.16B
+6.17%+10.22%+163.15%+166.44% 11.85B
Average +4.00%+6.45%+62.35%+134.21% 22.66B
Weighted average by Cap. +4.21%+7.70%+66.92%+143.19%

Financials

2024 2025
Net sales 39.92M 1.25M 1.1M 1.01M 945K 1.78M 118M 1.82M 12.17M 4.7M 58.37M 4.7M 4.6M 203M 48.19M 1.51M 1.32M 1.22M 1.14M 2.15M 143M 2.2M 14.7M 5.67M 70.48M 5.67M 5.55M 245M
Net income -158M -4.94M -4.33M -3.99M -3.73M -7.02M -467M -7.18M -48.05M -18.55M -230M -18.55M -18.14M -800M -164M -5.15M -4.51M -4.17M -3.89M -7.32M -487M -7.49M -50.12M -19.35M -240M -19.35M -18.93M -834M
Net Debt -382M -11.98M -10.49M -9.68M -9.04M -17.02M -1.13B -17.41M -117M -44.98M -559M -44.98M -43.99M -1.94B -54.59M -1.71M -1.5M -1.38M -1.29M -2.43M -162M -2.49M -16.65M -6.43M -79.84M -6.43M -6.29M -277M
Logo Enimmune corporation
ENIMMUNE CORP. is a Taiwan-based biotechnology new drug company mainly engaged in the development, produce and distribution of new drugs. The Company's new drug products include biological agents, monoclonal antibodies, vaccines, and small molecule drugs. The Company mainly conducts drug testing business, biotechnology service business, international trade business, western medicine wholesale and retail business. The product is Tuberculin PPD.
Employees
-
Date Price Change Volume
29/06/26 NT$15.95 +3.24% 77,050
26/06/26 NT$15.45 -3.44% 71,853
25/06/26 NT$16.00 -2.44% 43,027
24/06/26 NT$16.40 +0.61% 76,764
23/06/26 NT$16.30 -0.91% 120,859
  1. Stock Market
  2. Stocks
  3. 6564 Stock